Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 58 (IGLVV-58) is a pseudogene within the immunoglobulin lambda variable gene locus on human chromosome 22. The locus contains several variable region genes that enable antibody diversity, but IGLVV-58 itself does not encode a functional protein and is not implicated in immune function, disease association, or drug targeting[4][3]. Its designation exists for cataloguing genomic sequence variants, not as a biological entity with therapeutic relevance.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 58 (IGLVV-58).